Biotechnological Potential and Safety Evaluation of Dextran- and Riboflavin-Producing Weisella cibaria Strains for Gluten-Free Baking
- PMID: 38201097
- PMCID: PMC10778100
- DOI: 10.3390/foods13010069
Biotechnological Potential and Safety Evaluation of Dextran- and Riboflavin-Producing Weisella cibaria Strains for Gluten-Free Baking
Abstract
Gluten consumption causes several immunological and non-immunological intolerances in susceptible individuals. In this study, the dextran-producing Weissella cibaria BAL3C-5 and its derivative, the riboflavin-overproducing strain BAL3C-5 C120T, together with a commercial bakery yeast, were used to ferment gluten-free (GF)-doughs obtained from corn and rice flours at two different concentrations and supplemented with either quinoa, buckwheat, or chickpea to obtain laboratory-scale GF bread. The levels of dextran, riboflavin, and total flavins were determined in the fermented and breads. Both strains grew in fermented doughs and contributed dextran, especially to those made with corn plus quinoa (~1 g/100 g). The highest riboflavin (350-150 µg/100 g) and total flavin (2.3-1.75 mg/100 g) levels were observed with BAL3C-5 C120T, though some differences were detected between the various doughs or breads, suggesting an impact of the type of flour used. The safety assessment confirmed the lack of pathogenic factors in the bacterial strains, such as hemolysin and gelatinase activity, as well as the genetic determinants for biogenic amine production. Some intrinsic resistance to antibiotics, including vancomycin and kanamycin, was found. These results indicated the microbiological safety of both W. cibaria strains and indicated their potential application in baking to produce GF bread.
Keywords: Weissella cibaria; clean label; dextrans; functional bread; gluten-free; riboflavin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10778100/bin/foods-13-00069-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10778100/bin/foods-13-00069-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10778100/bin/foods-13-00069-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10778100/bin/foods-13-00069-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10778100/bin/foods-13-00069-g005.gif)
Similar articles
-
A methodology for the selection and characterization of riboflavin-overproducing Weissella cibaria strains after treatment with roseoflavin.Front Microbiol. 2023 Apr 6;14:1154130. doi: 10.3389/fmicb.2023.1154130. eCollection 2023. Front Microbiol. 2023. PMID: 37089563 Free PMC article.
-
Weissella cibaria riboflavin-overproducing and dextran-producing strains useful for the development of functional bread.Front Nutr. 2022 Oct 4;9:978831. doi: 10.3389/fnut.2022.978831. eCollection 2022. Front Nutr. 2022. PMID: 36267909 Free PMC article.
-
The genus Weissella: taxonomy, ecology and biotechnological potential.Front Microbiol. 2015 Mar 17;6:155. doi: 10.3389/fmicb.2015.00155. eCollection 2015. Front Microbiol. 2015. PMID: 25852652 Free PMC article. Review.
-
Evaluation of exopolysaccharide producing Weissella cibaria MG1 strain for the production of sourdough from various flours.Food Microbiol. 2014 Feb;37:44-50. doi: 10.1016/j.fm.2013.06.009. Epub 2013 Jun 22. Food Microbiol. 2014. PMID: 24230472
-
Sourdough in gluten-free bread-making: an ancient technology to solve a novel issue?Food Microbiol. 2009 Oct;26(7):676-84. doi: 10.1016/j.fm.2009.07.001. Epub 2009 Jul 26. Food Microbiol. 2009. PMID: 19747600 Review.
References
-
- Al-Toma A., Volta U., Auricchio R., Castillejo G., Sanders D.S., Cellier C., Mulder C.J., Lundin K.E.A. European Society for the Study of Coeliac Disease (ESsCD) Guideline for Coeliac Disease and Other Gluten-Related Disorders. United Eur. Gastroenterol. J. 2019;7:583–613. doi: 10.1177/2050640619844125. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources